Caption Management »

Inhibrx Biosciences shares owned by Caption Management

Quarter-by-quarter ownership of Inhibrx Biosciences shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Caption Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.8M 200k 14.17

More positions owned by Caption Management

First Solar Call Option (FSLR)
Alnylam Pharmaceuticals Call Option (ALNY)
Citigroup Com New Call Option (C)
Verizon Communications Put Option (VZ)
Caterpillar Call Option (CAT)
Insmed Com Par $.01 Call Option (INSM)
Snowflake Cl A Call Option (SNOW)
Capri Holdings SHS Call Option (CPRI)
Spdr Ser Tr S&p Regl Bkg Put Option (KRE)
Sarepta Therapeutics Call Option (SRPT)
United States Steel Corporation Call Option (X)
AmerisourceBergen Call Option (COR)
Alphabet Cap Stk Cl C Put Option (GOOG)
Adobe Systems Incorporated Put Option (ADBE)
Celestica Call Option (CLS)

View all positions for Caption Management

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
BlackRock
Vanguard Group
Sofinnova Ventures
Slotnik Capital
Alpine Associates Management
Millennium Management
TIG Advisors
Morgan Stanley
Ikarian Capital
Geode Capital Management
Caption Management
Marshall Wace
CSS

View all funds holding Inhibrx Biosciences